Apr 25, 2018 8:00am EDT Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018
Apr 16, 2018 2:00pm EDT Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting
Apr 06, 2018 8:00am EDT Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
Mar 15, 2018 7:30am EDT Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells
Mar 15, 2018 7:30am EDT Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
Mar 05, 2018 12:12pm EST Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018
Jan 08, 2018 8:00am EST Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company
Jan 08, 2018 8:00am EST Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 billion Target Cell Dose
